ERBB2 and breast cancer: In one study, a single-chain antibody against the Her2/neu receptor (ErbB2) was cloned in the viral genome to confer tropism toward tumoral cells, but the engineered VSV showed poor replication in ErbB2-expressing mammary cancer cells, and directed evolution was used to improve this trait (Gao et al. 2006).